Pharmaceuticals

Latest KFF Health News Stories

Graphic: Opioid Painkiller Is Top Prescription In 10 States

KFF Health News Original

Though opioid prescriptions appear to be on the decline, Vicodin and Norco remain popular, especially in the South. In more than half of states, Synthroid — a drug to treat hypothyroidism — came in at No. 1.

Congress Tackles The Opioid Epidemic. But How Much Will It Help?

KFF Health News Original

President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.

Use Of HIV-Prevention Drug Grows, But Lags Among Non-Whites

KFF Health News Original

The pill, known as PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years — but primarily among a white demographic.

Black Men’s Blood Pressure Is Cut Along With Their Hair

KFF Health News Original

A new study shows that educational sessions about high blood pressure at African American barbershops, coupled with prescribing and helping to manage medication, reduced hypertension rates significantly.

Campus Voices: Should Student Health Centers Offer Abortion Pills?

KFF Health News Original

California lawmakers are considering a bill that would require student health centers at all of the state’s four-year public universities to carry the abortion pill. Students at campuses across the state sounded off on the proposal.

Podcast: KHN’s ‘What The Health?’ HHS Leaders Take To The Stump

KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and new podcast panelist Anna Edney of Bloomberg News discuss this week’s spate of speeches by the leaders of the Department of Health and Human Services. They also discuss the slow progress on health legislation on Capitol Hill intended to fund the government and stabilize the individual insurance market. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.

Of ‘Miracles’ And Money: Why Hemophilia Drugs Are So Expensive

KFF Health News Original

The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn’t worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.

Jury’s In: Opioids Are Not Better Than Other Medicines For Chronic Pain

KFF Health News Original

A new study followed patients with severe chronic pain for a year and found that opioids relieved pain and increased function no better than common drugs like acetaminophen and lidocaine. But the opioids carry the risk of more serious side effects, including addiction and death.

Para abaratar el costo de los medicamentos, estados quieren importarlos de Canadá

KFF Health News Original

Algunos estados buscan impulsar al gobierno federal para que allane el camino para comprar stocks de medicamentos en Canadá con el fin de abaratar los costos y ahorrarle dinero a las arcas estatales.